Corning Leader, April 27, 2012
Corning Inc. is developing a glass that kills drug-resistant bacteria and viruses, and the company believes the innovation has applications in hospitals and beyond. Corning Inc. CEO Wendell Weeks revealed the project Thursday during the company's annual shareholders meeting at the Corning Museum of Glass. Although it is still in development, the so-called anti-microbial glass has shown it can kill 99 percent of viruses and bacteria it contacts, including methicillin-resistant Staphylococcus aureus, or MRSA, Weeks said. Weeks said the project is a response to the hundreds of thousands of people annually who acquire serious infections while being treated at U.S. hospitals.